| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |